TrialDiabetes technology & therapeutics2022

Continuous Glucose Monitoring Sensor Glucose Levels and Insulin Pump Infusion Set Wear-Time During Treatment with Fast-Acting Insulin Aspart: A Post Hoc Analysis of Onset 5.

Anders Gorst-Rasmussen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.